Brian Yu

5.3k total citations · 1 hit paper
65 papers, 2.3k citations indexed

About

Brian Yu is a scholar working on Epidemiology, Molecular Medicine and Pharmacology. According to data from OpenAlex, Brian Yu has authored 65 papers receiving a total of 2.3k indexed citations (citations by other indexed papers that have themselves been cited), including 18 papers in Epidemiology, 18 papers in Molecular Medicine and 15 papers in Pharmacology. Recurrent topics in Brian Yu's work include Antibiotic Resistance in Bacteria (18 papers), Antibiotics Pharmacokinetics and Efficacy (15 papers) and Pneumonia and Respiratory Infections (12 papers). Brian Yu is often cited by papers focused on Antibiotic Resistance in Bacteria (18 papers), Antibiotics Pharmacokinetics and Efficacy (15 papers) and Pneumonia and Respiratory Infections (12 papers). Brian Yu collaborates with scholars based in United States, Hong Kong and China. Brian Yu's co-authors include Anthony T.�C. Chan, Frankie Mo, Michael K. M. Kam, Benny Zee, Samuel K.W. Chiu, W. H. Kwan, Rosalie Ho, Edwin P. Hui, Brigette Ma and Ann D. King and has published in prestigious journals such as Circulation, Journal of Clinical Oncology and Blood.

In The Last Decade

Brian Yu

60 papers receiving 2.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Prospective Randomized Study of Intensity-Modulated Radiotherapy on Salivary Gland Function in Early-Stage Nasopharyngeal Carcinoma Patients

2007 544 citations Michael K. M. Kam, Sing-Fai Leung et al. Journal of Clinical Oncology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Brian Yu United States	21	1.1k	752	596	513	414	65	2.3k
Alberto Terzi Italy	24	22 0.0×	488 0.6×	1.0k 1.7×	618 1.2×	158 0.4×	105	2.2k
Imjai Chitapanarux Thailand	24	512 0.5×	613 0.8×	498 0.8×	589 1.1×	7 0.0×	172	2.0k
Li Xu United States	23	219 0.2×	342 0.5×	237 0.4×	681 1.3×	21 0.1×	90	1.8k
Francesco Ardito Italy	28	47 0.0×	1.3k 1.7×	683 1.1×	758 1.5×	21 0.1×	147	2.3k
Ji Yun Lee South Korea	24	82 0.1×	281 0.4×	662 1.1×	708 1.4×	17 0.0×	105	1.9k
Alexandra Rousseau France	26	89 0.1×	172 0.2×	357 0.6×	995 1.9×	13 0.0×	94	2.7k
Ourania Nicolatou‐Galitis Greece	25	931 0.9×	165 0.2×	1.5k 2.5×	1.3k 2.5×	11 0.0×	44	2.5k
Luigi Barzan Italy	33	1.9k 1.8×	1.3k 1.7×	656 1.1×	1.7k 3.3×	2 0.0×	103	3.8k
Kusum Joshi India	24	88 0.1×	426 0.6×	463 0.8×	416 0.8×	18 0.0×	122	2.2k

Countries citing papers authored by Brian Yu

Since Specialization

Citations

This map shows the geographic impact of Brian Yu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Brian Yu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Brian Yu more than expected).

Fields of papers citing papers by Brian Yu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Brian Yu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Brian Yu. The network helps show where Brian Yu may publish in the future.

Co-authorship network of co-authors of Brian Yu

This figure shows the co-authorship network connecting the top 25 collaborators of Brian Yu. A scholar is included among the top collaborators of Brian Yu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Brian Yu. Brian Yu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Yu, Brian, Sung Jun, Austin J. Iovoli, et al.. (2023). Association of pretreatment lymphocyte-monocyte ratio with survival outcome in patients with head and neck cancer treated with chemoradiation.. Journal of Clinical Oncology. 41(16_suppl). 6052–6052. 1 indexed citations

Yu, Brian, et al.. (2023). Physical Activity Misinformation on Social Media and Digital Mediums: Systematic Review. PsyArXiv (OSF Preprints). 1 indexed citations

Yu, Brian, et al.. (2022). Deconvoluting the Cells of the Human Heart with iPSC Technology: Cell Types, Protocols, and Uses. Current Cardiology Reports. 24(5). 487–496. 8 indexed citations

Yu, Brian, et al.. (2022). Involvement of Rho-Associated Coiled-Coil Containing Kinase (ROCK) in BCR-ABL1 Tyrosine Kinase Inhibitor Cardiovascular Toxicity. JACC CardioOncology. 4(3). 371–383. 6 indexed citations

Kollef, Marin H., Jean‐François Timsit, Ignacio Martín‐Loeches, et al.. (2022). Outcomes in participants with failure of initial antibacterial therapy for hospital-acquired/ventilator-associated bacterial pneumonia prior to enrollment in the randomized, controlled phase 3 ASPECT-NP trial of ceftolozane/tazobactam versus meropenem. Critical Care. 26(1). 373–373. 10 indexed citations

Nicolau, David P., Jan J. De Waele, Joseph L. Kuti, et al.. (2021). Pharmacokinetics and Pharmacodynamics of Ceftolozane/Tazobactam in Critically Ill Patients With Augmented Renal Clearance. International Journal of Antimicrobial Agents. 57(4). 106299–106299. 27 indexed citations

Timsit, Jean‐François, Jennifer A. Huntington, Richard G. Wunderink, et al.. (2021). Ceftolozane/tazobactam versus meropenem in patients with ventilated hospital-acquired bacterial pneumonia: subset analysis of the ASPECT-NP randomized, controlled phase 3 trial. Critical Care. 25(1). 290–290. 26 indexed citations

Johnson, Matthew G., Christopher Bruno, Mariana Castanheira, et al.. (2021). Evaluating the emergence of nonsusceptibility among Pseudomonas aeruginosa respiratory isolates from a phase-3 clinical trial for treatment of nosocomial pneumonia (ASPECT-NP). International Journal of Antimicrobial Agents. 57(3). 106278–106278. 15 indexed citations

Cesar, Spencer, Brian Yu, Enrique Rojas, et al.. (2020). Bacterial Evolution in High-Osmolarity Environments. mBio. 11(4). 15 indexed citations

10.

Ang, Jocelyn Y., Antonio Arrieta, John S. Bradley, et al.. (2020). Ceftolozane/Tazobactam in Neonates and Young Infants: The Challenges of Collecting Pharmacokinetics and Safety Data in This Vulnerable Patient Population. American Journal of Perinatology. 38(8). 804–809. 13 indexed citations

11.

Yu, Brian, et al.. (2019). RELATIONSHIP BETWEEN GLOBAL LONGITUDINAL STRAIN AND LEFT VENTRICULAR DIASTOLIC FUNCTION. Journal of the American College of Cardiology. 73(9). 1675–1675. 7 indexed citations

12.

Kollef, Marin H., Martin Nováček, Álvaro Réa-Neto, et al.. (2019). Ceftolozane–tazobactam versus meropenem for treatment of nosocomial pneumonia (ASPECT-NP): a randomised, controlled, double-blind, phase 3, non-inferiority trial. The Lancet Infectious Diseases. 19(12). 1299–1311. 230 indexed citations

13.

Yu, Brian, et al.. (2018). THE FEASIBILITY OF GLOBAL LONGITUDINAL STRAIN IN CLINICAL PRACTICE AND RELATIONSHIP WITH EJECTION FRACTION. Journal of the American College of Cardiology. 71(11). A1716–A1716.

14.

Thein, Hla‐Hla, Kika Anyiwe, Nathaniel Jembere, et al.. (2017). Effects of socioeconomic status on esophageal adenocarcinoma stage at diagnosis, receipt of treatment, and survival: A population-based cohort study. PLoS ONE. 12(10). e0186350–e0186350. 13 indexed citations

15.

Yeung, Rebecca M.W., et al.. (2013). ‘Who’, ‘when’ and ‘how’ in re-irradiation of recurrent painful bone metastases. Journal of bone oncology. 2(1). 33–37. 1 indexed citations

16.

Vlantis, Alexander C., et al.. (2010). Surgical salvage nasopharyngectomy for recurrent nasopharyngeal carcinoma: A multivariate analysis of prognostic factors. Head & Neck. 33(8). 1126–1131. 23 indexed citations

17.

Ma, Brigette, Edwin P. Hui, Sze Chuen Cesar Wong, et al.. (2009). Multicenter phase II study of gemcitabine and oxaliplatin in advanced nasopharyngeal carcinoma—correlation with excision repair cross-complementing-1 polymorphisms. Annals of Oncology. 20(11). 1854–1859. 48 indexed citations

18.

Hui, Edwin P., Brigette Ma, Sing Fai Leung, et al.. (2008). Randomized Phase II Trial of Concurrent Cisplatin-Radiotherapy With or Without Neoadjuvant Docetaxel and Cisplatin in Advanced Nasopharyngeal Carcinoma. Journal of Clinical Oncology. 27(2). 242–249. 406 indexed citations

19.

Kam, Michael K. M., Sing-Fai Leung, Benny Zee, et al.. (2007). Prospective Randomized Study of Intensity-Modulated Radiotherapy on Salivary Gland Function in Early-Stage Nasopharyngeal Carcinoma Patients. Journal of Clinical Oncology. 25(31). 4873–4879. 544 indexed citations breakdown →

20.

Vlantis, Alexander C., Raymond K. Tsang, Brian Yu, et al.. (2007). Nasopharyngectomy and Surgical Margin Status. Archives of Otolaryngology - Head and Neck Surgery. 133(12). 1296–1296. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact